Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CRNX	CRINETICS PHARMACEUTICALS INC	$2.78B	-30.90%	-28.10%	-25.17%	-35.80%	0.09	22.53	100.00%	-43,191.10%	-43,191.05%
CATX	PERSPECTIVE THERAPEUTICS INC	$289.63M	-32.50%	-27.70%	-32.51%	-53.00%	0.17	15.09	100.00%	-7,688.50%	-7,838.62%
BLRX	BIOLINERX LTD	$16.83M	-23.90%	-6.80%	17.68%	50.20%	1.09	2.28	64.90%	-15.20%	23.33%
ABVX	ABIVAX SA	$4.41B	N/A	N/A	N/A	N/A	-26.32	1.26	N/A	N/A	N/A
TIL	INSTIL BIO INC	$190.67M	-54.30%	-33.70%	-35.38%	-24.40%	0.75	14.97	N/A	N/A	N/A
GOSS	GOSSAMER BIO INC	$445.67M	-1,774.70%	-46.70%	-70.10%	-31.50%	-6.23	4.40	100.00%	-344.80%	-326.37%
CVRX	CVRX INC	$189.34M	-79.30%	-41.00%	-42.66%	-70.20%	1.06	11.99	83.50%	-95.60%	-85.77%
ACB	AURORA CANNABIS INC	$303.20M	-5.90%	-3.90%	-3.30%	-4.10%	0.45	2.97	47.80%	-9.10%	-6.28%
INMB	INMUNE BIO INC	$65.13M	-171.70%	-132.30%	-190.76%	993.00%	0.31	4.20	100.00%	-111,016.00%	-111,016.00%
CLRB	CELLECTAR BIOSCIENCES INC	$6.79M	-196.00%	-90.70%	-244.25%	257.60%	0.78	2.47	N/A	N/A	N/A
LFWD	LIFEWARD LTD	$6.74M	-102.00%	-70.50%	-139.08%	-351.80%	0.56	2.19	35.20%	-108.20%	-108.02%
ALXO	ALX ONCOLOGY HOLDINGS INC	$35.08M	-115.70%	-84.80%	-150.24%	-107.50%	0.48	4.52	N/A	N/A	N/A
MXCT	MAXCYTE INC	$150.32M	-22.10%	-19.10%	-21.50%	-21.30%	0.15	12.40	79.80%	-125.20%	-125.22%
AMIX	AUTONOMIX MEDICAL INC	$5.81M	-172.90%	-133.40%	-169.41%	1,348.80%	0.28	4.57	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$250.83M	N/A	-1,160.80%	-1,135.37%	-3,792.40%	-1.14	3.49	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$161.49M	-450.90%	-333.20%	-1,262.96%	1,276.50%	1.10	1.91	N/A	N/A	N/A
PSTV	PLUS THERAPEUTICS INC	$17.73M	N/A	-294.10%	-1,313.89%	267.30%	-1.51	1.03	100.00%	-520.90%	-377.81%
DSGN	DESIGN THERAPEUTICS INC	$293.85M	-27.10%	-26.10%	-29.65%	-29.50%	0.05	25.13	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$65.95M	-42.60%	-37.80%	-47.37%	-46.40%	0.14	13.84	N/A	N/A	N/A
VNDA	VANDA PHARMACEUTICALS INC	$261.76M	-12.90%	-10.50%	-16.89%	-25.70%	0.29	3.25	94.40%	-32.90%	-41.77%
ACET	ADICET BIO INC	$53.76M	-59.10%	-50.70%	-67.11%	-93.10%	0.19	9.34	N/A	N/A	N/A
KLTO	KLOTHO NEUROSCIENCES INC	$25.31M	-1,779.90%	-275.00%	-1,046.94%	-2,476.20%	3.68	0.29	N/A	N/A	N/A
HUMA	HUMACYTE INC	$297.74M	N/A	-42.40%	-40.92%	-44.80%	33.25	2.45	56.00%	-7,171.30%	-5,888.75%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$7.94M	-85.30%	-81.50%	-75.55%	3,422.40%	0.04	27.39	60.00%	-43,500.20%	-43,500.24%
AURA	AURA BIOSCIENCES INC	$434.84M	-64.40%	-54.20%	-53.41%	-72.20%	0.17	12.39	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$70.00M	-69.60%	-54.70%	-80.20%	-67.00%	0.32	7.75	N/A	N/A	N/A
SVRA	SAVARA INC	$520.24M	-69.10%	-54.80%	-73.49%	-55.80%	0.36	11.08	N/A	N/A	N/A
LYEL	LYELL IMMUNOPHARMA INC	$206.71M	-85.60%	-68.90%	-95.08%	-86.80%	0.29	7.65	100.00%	-625,277.40%	-625,277.36%
MRNA	MODERNA INC	$10.38B	-27.50%	-21.20%	-28.21%	-26.80%	0.28	3.93	52.50%	-94.30%	-95.68%
ENGN	ENGENE HOLDINGS INC	$184.49M	-32.60%	-28.30%	-30.82%	-49.30%	0.17	12.67	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-88.10%	-45.20%	-59.66%	3,668.10%	0.78	1.75	N/A	N/A	N/A
PTIX	PROTAGENIC THERAPEUTICS INC	$1.81M	-860.50%	-354.10%	5,933.56%	929.50%	-12.19	0.86	N/A	N/A	N/A
PROF	PROFOUND MEDICAL CORP	$166.49M	-80.90%	-65.70%	-66.88%	-254.80%	0.20	11.32	66.60%	-322.20%	-326.28%
MGNX	MACROGENICS INC	$102.39M	-40.20%	-14.60%	-16.70%	-37.80%	4.26	5.26	86.90%	-22.00%	-20.84%
TELO	TELOMIR PHARMACEUTICALS INC	$46.73M	-2,009.60%	-1,009.70%	7,774.94%	2,642.40%	-4.05	0.75	N/A	N/A	N/A
RXST	RXSIGHT INC	$334.04M	-9.50%	-8.50%	-9.12%	-9.50%	0.12	12.68	71.90%	-17.90%	-17.84%
ALUR	ALLURION TECHNOLOGIES INC	$18.57M	N/A	-57.80%	-103.38%	-27.60%	-1.55	2.09	66.40%	-86.00%	-82.25%
GRI	GRI BIO INC	$3.08M	-331.30%	-202.60%	-743.15%	753.30%	2.35	1.41	N/A	N/A	N/A
SAVA	CASSAVA SCIENCES INC	$116.42M	-93.30%	-74.90%	-139.88%	2,577.00%	0.54	2.43	N/A	N/A	N/A
KYTX	KYVERNA THERAPEUTICS INC	$153.09M	-64.90%	-56.10%	-84.94%	-89.40%	0.23	5.39	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$199.69M	-17.80%	-14.60%	-17.93%	-17.40%	0.18	18.64	100.00%	-92.30%	-96.77%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$886.54M	-52.90%	-41.30%	-50.08%	-89.20%	0.30	3.27	20.60%	-161.40%	-161.36%
LRMR	LARIMAR THERAPEUTICS INC	$364.62M	-62.90%	-54.00%	-80.90%	-71.70%	0.25	5.46	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$2.27B	-34.60%	-32.80%	-37.93%	-40.70%	0.06	16.36	N/A	N/A	N/A
FDMT	4D MOLECULAR THERAPEUTICS INC	$331.59M	-40.10%	-36.40%	-44.68%	-49.60%	0.13	8.75	100.00%	-594,375.80%	-594,375.76%
CMPS	COMPASS PATHWAYS PLC	$406.79M	-78.30%	-51.40%	-50.29%	-230.70%	0.81	8.82	N/A	N/A	N/A
IMTX	IMMATICS NV	$717.20M	-15.10%	-11.90%	-13.97%	-21.80%	0.22	8.80	100.00%	-56.80%	-54.78%
RGNX	REGENXBIO INC	$454.45M	-53.30%	-30.80%	-36.03%	-29.10%	0.79	2.94	79.10%	-100.60%	-88.33%
VRDN	VIRIDIAN THERAPEUTICS INC	$1.51B	-55.10%	-49.90%	-64.39%	-64.00%	0.13	11.01	100.00%	-112,806.90%	-111,835.74%
AQST	AQUESTIVE THERAPEUTICS INC	$409.86M	N/A	-63.90%	-68.16%	-35.30%	-2.29	3.53	61.10%	-147.40%	-108.95%
MDWD	MEDIWOUND LTD	$200.52M	-74.10%	-30.90%	-43.05%	-76.30%	1.21	2.15	14.40%	-110.50%	-105.70%
MRUS	MERUS NV	$5.06B	-55.30%	-46.20%	-45.90%	-98.30%	0.16	8.39	100.00%	-555.60%	-587.80%
MDCX	MEDICUS PHARMA LTD	$35.28M	-549.40%	-228.10%	-491.82%	1,512.90%	2.67	1.29	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$206.34M	-37.60%	-28.90%	-38.29%	-37.90%	0.32	5.43	100.00%	-349.20%	-347.02%
TECX	TECTONIC THERAPEUTIC INC	$457.89M	-30.10%	-28.30%	-22.86%	3,469.80%	0.04	25.60	N/A	N/A	N/A
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	$3.52B	-42.20%	-36.40%	-40.83%	-78.80%	0.29	16.65	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$1.07B	-21.30%	-20.30%	-22.96%	-25.90%	0.06	20.48	N/A	N/A	N/A
KRRO	KORRO BIO INC	$186.69M	-61.50%	-42.90%	-55.90%	-48.60%	0.57	5.98	100.00%	-1,454.50%	-1,452.95%
CTNM	CONTINEUM THERAPEUTICS INC	$203.58M	-29.80%	-28.10%	-32.37%	-32.90%	0.07	24.51	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$18.79k	-60.60%	-50.60%	-24.63%	-2,578.20%	0.05	10.17	N/A	N/A	N/A
DTIL	PRECISION BIOSCIENCES INC	$52.89M	-35.90%	-15.20%	-18.23%	-54.20%	1.52	6.63	100.00%	-43.00%	-39.94%
SANA	SANA BIOTECHNOLOGY INC	$815.68M	-115.30%	-54.00%	-76.84%	-120.30%	1.95	2.47	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$755.39M	-55.50%	-52.10%	-54.82%	-117.00%	0.08	12.74	N/A	N/A	N/A
CHRS	COHERUS BIOSCIENCES INC	$118.25M	N/A	-26.20%	-97.17%	-41.20%	-3.02	1.22	56.60%	-66.30%	-57.09%
OCS	OCULIS HOLDING AG	$988.98M	-92.70%	-69.90%	-62.07%	-169.90%	0.26	4.79	100.00%	-13,737.90%	-13,649.68%
CELC	CELCUITY INC	$1.96B	-96.20%	-49.40%	-62.15%	-37.50%	1.52	6.61	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$1.78B	-64.10%	-56.80%	-60.04%	-163.20%	0.28	16.83	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$14.14M	-101.90%	-83.00%	-87.87%	-9,855.80%	0.17	6.79	100.00%	-224.40%	-223.57%
CYBN	CYBIN INC	$154.88M	-44.70%	-42.70%	-47.70%	-769.80%	0.09	7.75	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$5.01M	-475.70%	-184.00%	33.59%	-399.30%	0.42	3.41	N/A	N/A	N/A
MDAI	SPECTRAL AI INC	$56.14M	N/A	-94.80%	7,785.31%	5,113.20%	-2.75	0.87	45.30%	-52.00%	-50.02%
DNTH	DIANTHUS THERAPEUTICS INC	$651.24M	-29.30%	-27.90%	-30.38%	-40.00%	0.06	15.99	100.00%	-1,544.00%	-1,544.02%
ABSI	ABSCI CORP	$448.57M	-60.20%	-50.90%	-63.13%	-110.20%	0.21	4.39	100.00%	-2,737.90%	-2,724.43%
PRTA	PROTHENA CORP PUBLIC LTD CO	$433.87M	-67.90%	-59.50%	-78.99%	-1,191.10%	0.23	5.69	100.00%	-2,929.30%	-2,530.46%
OCUL	OCULAR THERAPEUTIX INC	$2.20B	-70.00%	-48.00%	-50.05%	-212.70%	0.48	10.10	89.40%	-382.50%	-360.75%
SLXN	SILEXION THERAPEUTICS CORP	$5.38M	N/A	-301.70%	-305.76%	-389.00%	47.31	2.44	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$84.48M	-44.80%	-37.10%	-42.03%	-302.20%	0.28	18.43	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$217.58M	-61.20%	-28.10%	-36.59%	3,848.40%	1.05	3.76	100.00%	-231.50%	-222.96%
TLRY	TILRAY BRANDS INC	$1.30B	-78.20%	-62.80%	-126.97%	-192.70%	0.39	2.46	29.30%	-266.30%	-277.34%
WVE	WAVE LIFE SCIENCES LTD	$1.42B	-78.40%	-41.50%	-78.74%	302.50%	0.76	2.56	100.00%	-138.20%	-138.24%
AGIO	AGIOS PHARMACEUTICALS INC	$2.13B	43.30%	40.10%	49.57%	47.20%	0.07	14.48	88.20%	1,590.40%	1,698.66%
PLRX	PLIANT THERAPEUTICS INC	$96.68M	-67.60%	-52.50%	-68.28%	-59.60%	0.34	11.03	N/A	N/A	N/A
MURA	MURAL ONCOLOGY PLC	$30.66M	-122.30%	-99.40%	-248.83%	-582.70%	0.49	2.87	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$80.53M	-32.50%	-29.60%	-49.22%	-51.80%	0.07	16.75	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$6.73B	-41.80%	-35.60%	-36.16%	-43.60%	0.30	11.79	N/A	N/A	N/A
RXRX	RECURSION PHARMACEUTICALS INC	$2.45B	-76.10%	-54.30%	-57.02%	-278.70%	0.42	3.58	-3.50%	-1,004.90%	-1,004.89%
WHWK	WHITEHAWK THERAPEUTICS INC	$76.32M	26.20%	22.50%	12.50%	111.70%	0.06	18.95	88.70%	99.40%	99.77%
QSI	QUANTUM-SI INC	$226.79M	-47.60%	-42.20%	-46.17%	-50.70%	0.15	9.43	53.20%	-3,120.10%	-3,117.58%
KPTI	KARYOPHARM THERAPEUTICS INC	$40.32M	N/A	-84.30%	-1,390.78%	-39.60%	-1.44	0.99	96.40%	-90.00%	-57.38%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$143.52M	-289.40%	-110.00%	-270.39%	-180.20%	144.17	2.10	92.70%	-2,367.50%	-2,366.27%
CRVO	CERVOMED INC	$88.68M	-44.10%	-40.60%	-53.91%	-56.50%	0.11	9.78	100.00%	-200.60%	-200.58%
PCVX	VAXCYTE INC	$4.08B	-16.90%	-15.90%	-17.38%	-19.20%	0.08	11.11	N/A	N/A	N/A
ADVM	ADVERUM BIOTECHNOLOGIES INC	$58.13M	-332.80%	-113.50%	-283.66%	-121.10%	-5.76	1.54	100.00%	-18,387.40%	-18,387.40%
ETNB	89BIO INC	$1.33B	-81.40%	-70.20%	-58.76%	-105.30%	0.13	18.03	N/A	N/A	N/A
EVH	EVOLENT HEALTH INC	$1.04B	-19.10%	-7.30%	-6.72%	-18.30%	1.49	1.01	16.40%	-8.40%	-5.83%
CBUS	CIBUS INC	$50.55M	-203.20%	-68.40%	-76.61%	-92.90%	3.72	1.23	100.00%	-5,784.90%	-5,063.86%
GUTS	FRACTYL HEALTH INC	$49.13M	-596.40%	-105.00%	-248.34%	-118.80%	-4.41	1.22	58.80%	-586,864.70%	-586,864.71%
OLMA	OLEMA PHARMACEUTICALS INC	$361.02M	-42.60%	-38.60%	-40.79%	-53.10%	0.11	11.09	N/A	N/A	N/A
CLDI	CALIDI BIOTHERAPEUTICS INC	$13.35M	N/A	-203.90%	-198.58%	-815.00%	1.12	2.12	N/A	N/A	N/A
LGVN	LONGEVERON INC	$11.46M	-96.70%	-80.30%	-137.68%	-685.10%	0.32	3.43	78.80%	-901.50%	-894.31%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	637	+0.16%	+4.39%	+5.40%	-64.07%	-120.55x	4.49x	-118.72%	-6.90%	-1.22%	+91.91%	Strong Buy
Diagnostics & Research	57	-0.65%	+5.82%	+10.75%	-11.64%	23.48x	3.86x	-3.64%	+7.31%	+15.56%	+6.42%	Buy
Drug Manufacturers - General	18	+1.22%	+4.73%	-2.89%	-13.96%	35.06x	5.95x	+58.83%	+10.36%	+17.82%	+52.31%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.28%	+7.01%	+1.44%	-66.95%	-12.37x	2.25x	+12.30%	+4.94%	+10.47%	+33.61%	Buy
Healthcare Plans	11	+0.15%	+7.00%	-6.09%	-38.26%	13.93x	1.88x	+15.64%	+4.90%	+11.41%	+25.76%	Buy
Health Information Services	55	-0.70%	+5.29%	+3.12%	-55.42%	83.62x	4.08x	+7.18%	+4.90%	+9.58%	+21.87%	Strong Buy
Medical Care Facilities	48	-0.63%	+4.80%	+0.49%	-32.55%	15.96x	4.72x	-194.68%	+6.86%	+15.22%	+19.15%	Buy
Medical Devices	141	-0.80%	+4.06%	-1.62%	-20.79%	31.63x	4.01x	+13.96%	+8.53%	+10.15%	+30.11%	Strong Buy
Medical Distribution	10	+1.29%	+2.12%	-4.82%	+20.45%	26.54x	286.70x	-6.88%	+3.01%	+18.69%	+15.90%	Buy
Medical Instruments & Supplies	55	-1.07%	+2.00%	+0.19%	-60.20%	33.51x	3.51x	+10.62%	+8.37%	+11.14%	+23.54%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 20 points higher than the healthcare sector average of 25. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 70.29% over the past year, overperforming other healthcare stocks by 119 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, a downside of -0.23% from Phibro Animal Health's current stock price of $30.57.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: D, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 11 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -6.1% over the past year, overperforming other healthcare stocks by 42 percentage points.

Embecta has an average 1 year price target of $12.00, a downside of -13.48% from Embecta's current stock price of $13.87.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 59.39% over the past year, overperforming other healthcare stocks by 108 percentage points.

Theravance Biopharma has an average 1 year price target of $21.33, an upside of 64.86% from Theravance Biopharma's current stock price of $12.94.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Simulations Plus (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.95%. Simulations Plus's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Simulations Plus's dividend has shown consistent growth over the last 10 years.

Simulations Plus's dividend payout ratio of -1.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 1.95%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

3. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.1%, which is 12 percentage points higher than the healthcare sector average of 1.95%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.19% in the last day, and up 4.59% over the last week. Onemednet was the among the top losers in the healthcare sector, dropping -33.06% yesterday.

OneMedNet shares are trading higher after the company reported a year-over-year increase in Q2 EPS results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -6.1% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 4.6% in the past year. It has overperformed other stocks in the healthcare sector by 53 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 116.23% in the past year. It has overperformed other stocks in the healthcare sector by 165 percentage points.

Are healthcare stocks a good buy now?

50.6% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.32% over the next year.

5.45% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.32% of healthcare stocks are rated B (Buy), 42.3% are rated C (Hold), 26.54% are rated D (Sell), and 13.39% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 6.78x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.